Inherent Biosciences Raises Seed Round, Adds Board Members and Clinical Advisors
Funding will be used to clinically validate and launch the company s proprietary male infertility diagnostic
News provided by
Share this article
Share this article
SALT LAKE CITY, Feb. 17, 2021 /PRNewswire/ Inherent Biosciences today announced its initial capital raise led by Morning Star Foundation with additional participation from MedMountain Ventures, Kickstart Funds, Park City Angels, Rhythm VC and several angel investors. With the initial funding, Inherent will launch a male infertility diagnostic to guide infertility treatment.
Inherent also added members to its Board of Directors and Clinical Advisors:
Lewis Rumpler - Former CEO of Epigenesys, Executive Chairman
Inherent Biosciences Raises Seed Round, Adds Board Members and Clinical Advisors prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.